Remarkably, electroconvulsive therapy was able to suppress depression-like behaviors and increased the extent of AQP-4 immunoreactive processes around blood vessels in the rat genetic model (Azis et al., 2019). This evidence concerns the gene AQP4 and depressive symptom measurement.